Médecins sans Frontières, Medical Department (Operational Research), Brussels Operational Center, 68 Rue de Gasperich, L-1617, Luxembourg.
Trans R Soc Trop Med Hyg. 2010 May;104(5):313-9. doi: 10.1016/j.trstmh.2010.01.007. Epub 2010 Feb 6.
A study conducted among HIV-positive adults in WHO clinical stages 1 and 2 was followed up at Thyolo District Hospital (rural Malawi) to report on: (1) retention and attrition before and while on antiretroviral treatment (ART); and (2) the criteria used for initiating ART. Between June 2008 and January 2009, 1633 adults in WHO stages 1 and 2 were followed up for a total of 282 person-years. Retention in care at 1, 2, 3 and 6 months for those not on ART (n=1078) was 25, 18, 11 and 4% vs. 99, 97, 95 and 90% for patients who started ART (n=555, P=0.001). Attrition rates were 31 times higher among patients not started on ART compared with those started on ART (adjusted hazard ratio, 31.0, 95% CI 22-44). Ninety-two patients in WHO stage 1 or 2 were started on ART without the guidance of a CD4 count, and 11 were incorrectly started on ART with CD4 count > or = 250 cells/mm(3). In a rural district hospital setting in Malawi, attrition of individuals in WHO stages 1 and 2 is unacceptably high, and specific operational strategies need to be considered to retain such patients in the health system.
一项在世界卫生组织(WHO)临床分期 1 和 2 的 HIV 阳性成人中开展的研究,在 Thyolo 地区医院(马拉维农村地区)进行了随访,以报告:(1)在开始抗逆转录病毒治疗(ART)之前和期间的保留和流失情况;以及(2)启动 ART 的标准。在 2008 年 6 月至 2009 年 1 月期间,1633 名 WHO 分期 1 和 2 的成年人共随访了 282 人年。未接受 ART 治疗(n=1078)的患者在 1、2、3 和 6 个月时的保留率分别为 25%、18%、11%和 4%,而开始 ART 治疗(n=555)的患者分别为 99%、97%、95%和 90%(P=0.001)。未开始 ART 治疗的患者的流失率是开始 ART 治疗患者的 31 倍(调整后的危险比,31.0,95%CI 22-44)。92 名处于 WHO 分期 1 或 2 的患者在未进行 CD4 计数指导的情况下开始接受 ART 治疗,11 名患者的 CD4 计数>或=250 个细胞/mm(3)时被错误地开始接受 ART 治疗。在马拉维农村地区医院环境中,WHO 分期 1 和 2 患者的流失率高得令人无法接受,需要考虑具体的运营策略,以将此类患者保留在卫生系统中。